WASIR2 and lung adenocarcinoma: Similarly, it has been shown that WASIR2 knockdown suppressed the malignant activity of osteosarcoma cells; RPARP-AS1 and GAS5 can be used as prognostic biomarkers for lung adenocarcinoma (LUAD) and PCa, respectively [57,58,59].